Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabetes
Clinical trial NCT04854083 · UNKNOWN
Trial details
- NCT number
- NCT04854083
- Sponsor
- Kirsi Pietiläinen
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-17
- Primary completion
- 2025-08-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.